返回
NovaBay Pharmaceuticals Inc（NBY）價格
NBY 股價走勢圖
NBY 股利
NovaBay Pharmaceuticals Inc
$14.77
16.39%
$2.08
收盤價：Jan 16, 16:00:00 GMT-5
$12.91
-12.59%
$-1.85
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$12.69
開盤價
$12.3
當日範圍
$11.91 - $18.4
52週區間
$0.46 - $19.95
交易量
2.7M
平均成交量
1.2M
每股盈餘 (TTM)
-6.62
股息收益率
--
市值
$1.6B
什麼是 NBY？
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.